Wollert Kai C, Fiedler Beate, Gambaryan Stepan, Smolenski Albert, Heineke Jörg, Butt Elke, Trautwein Christian, Lohmann Suzanne M, Drexler Helmut
Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Hannover, Germany.
Hypertension. 2002 Jan;39(1):87-92. doi: 10.1161/hy1201.097292.
NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes with the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) (250 micromol/L) or the PKG-selective cGMP analog 8-pCPT-cGMP (500 micromol/L) activated endogenous PKG type I, as shown by the site-specific phosphorylation of vasodilator-stimulated phosphoprotein, a well-characterized PKG substrate. SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) modestly attenuated the hypertrophic response to alpha(1)-adrenergic stimulation with phenylephrine. Although a high concentration of SNAP (1000 micromol/L) promoted apoptosis in cardiomyocytes, as evidenced by the formation of histone-associated DNA fragments, antihypertrophic concentrations of SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote cell death. Because chronic activation downregulated endogenous PKG I, we explored whether gene transfer of PKG I would enhance the sensitivity of cardiomyocytes to the antihypertrophic effects of NO/cGMP. Indeed, after adenoviral overexpression of PKG Ibeta, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) completely suppressed the hypertrophic response to alpha(1)-adrenergic stimulation. As observed in noninfected cells, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote apoptosis in cardiomyocytes overexpressing PKG Ibeta. Moreover, overexpression of PKG Ibeta did not enhance the proapoptotic effects of 1000 micromol/L SNAP, implying PKG-independent effects of NO on apoptosis. Endogenous PKG I mediates antihypertrophic but not proapoptotic effects of NO in a cell culture model of cardiomyocyte hypertrophy. Adenoviral gene transfer of PKG I selectively enhances the antihypertrophic effects of NO without increasing the susceptibility to apoptosis.
通过可溶性鸟苷酸环化酶和环磷酸鸟苷(cGMP)生成起作用的一氧化氮(NO)是心肌细胞肥大的负调节因子。介导NO/cGMP对心肌细胞肥大抑制作用的下游靶点尚未阐明。除了其抗肥大作用外,NO还可能通过不依赖cGMP的途径促进心肌细胞凋亡。我们研究了cGMP依赖性蛋白激酶(PKG)在NO的抗肥大和促凋亡作用中的作用。用NO供体S-亚硝基-N-乙酰-D,L-青霉胺(SNAP)(250 μmol/L)或PKG选择性cGMP类似物8-对氯苯硫基-cGMP(8-pCPT-cGMP)(500 μmol/L)孵育新生大鼠心肌细胞,可激活内源性I型PKG,这可通过血管舒张刺激磷蛋白(一种已明确的PKG底物)的位点特异性磷酸化来证明。SNAP(250 μmol/L)和8-pCPT-cGMP(500 μmol/L)适度减弱了对苯肾上腺素α(1)-肾上腺素能刺激的肥大反应。尽管高浓度的SNAP(1000 μmol/L)可促进心肌细胞凋亡,这可通过组蛋白相关DNA片段的形成来证明,但抗肥大浓度的SNAP(250 μmol/L)和8-pCPT-cGMP(500 μmol/L)并未促进细胞死亡。由于慢性激活会下调内源性PKG I,我们探讨了PKG I的基因转移是否会增强心肌细胞对NO/cGMP抗肥大作用的敏感性。事实上,在腺病毒介导PKG Iβ过表达后,SNAP(250 μmol/L)和8-pCPT-cGMP(500 μmol/L)完全抑制了对α(1)-肾上腺素能刺激的肥大反应。如在未感染细胞中观察到的那样,SNAP(250 μmol/L)和8-pCPT-cGMP(500 μmol/L)并未促进过表达PKG Iβ的心肌细胞凋亡。此外,PKG Iβ的过表达并未增强1000 μmol/L SNAP的促凋亡作用,这意味着NO对凋亡有不依赖PKG的作用。在心肌细胞肥大的细胞培养模型中,内源性PKG I介导NO的抗肥大作用,但不介导其促凋亡作用。PKG I的腺病毒基因转移选择性增强了NO的抗肥大作用,而不增加对凋亡的易感性。